Compare ALCO & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALCO | INFU |
|---|---|---|
| Founded | 1960 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 314.2M | 196.1M |
| IPO Year | 1994 | 2005 |
| Metric | ALCO | INFU |
|---|---|---|
| Price | $40.84 | $9.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $44.00 | $15.00 |
| AVG Volume (30 Days) | 29.1K | ★ 100.6K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.48% | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | N/A | ★ 0.31 |
| Revenue | N/A | ★ $143,436,000.00 |
| Revenue This Year | N/A | $2.89 |
| Revenue Next Year | N/A | $7.66 |
| P/E Ratio | ★ N/A | $29.77 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $27.61 | $4.61 |
| 52 Week High | $43.20 | $11.04 |
| Indicator | ALCO | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 59.79 | 50.68 |
| Support Level | $39.99 | $8.52 |
| Resistance Level | $42.58 | $9.83 |
| Average True Range (ATR) | 1.23 | 0.39 |
| MACD | 0.32 | -0.08 |
| Stochastic Oscillator | 85.82 | 43.49 |
Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.